Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Badri

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal Francais D'Ophtalmologie|March 21, 2018
[Traumatic proptosis induced by forceps delivery]M Bouazza, S Badri, L Boutaqbout, et al.
The Journal of Infectious Diseases|February 1, 1977
Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant womenM S Badri, S Zawaneh, A C Cruz, et al.
Therapeutic Drug Monitoring|June 17, 2016
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C InfectionPrajakta S Badri, Apurvasena Parikh, Eoin P Coakley, et al.
Obesity Surgery|April 9, 2018
Role of Routine Abdominal Ultrasound Before Bariatric Surgery: Review of 937 PatientsBassem M Abou Hussein, Ali Khammas, Maryam Makki, et al.
Clinical Therapeutics|October 28, 2015
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese SubjectsJiuhong Zha, Prajakta S Badri, Bifeng Ding, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2015
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-RitonavirPrajakta S Badri, Sandeep Dutta, Haoyu Wang, et al.
Antiviral Therapy|September 2, 2016
Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trialsAkshanth R Polepally, Prajakta S Badri, Apurvasena Parikh, et al.
Journal of Hepatology|February 4, 2015
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvirRajeev M Menon, Prajakta S Badri, Tianli Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal Francais D'Ophtalmologie|March 21, 2018
[Traumatic proptosis induced by forceps delivery]M Bouazza, S Badri, L Boutaqbout, et al.
The Journal of Infectious Diseases|February 1, 1977
Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant womenM S Badri, S Zawaneh, A C Cruz, et al.
Therapeutic Drug Monitoring|June 17, 2016
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C InfectionPrajakta S Badri, Apurvasena Parikh, Eoin P Coakley, et al.
Obesity Surgery|April 9, 2018
Role of Routine Abdominal Ultrasound Before Bariatric Surgery: Review of 937 PatientsBassem M Abou Hussein, Ali Khammas, Maryam Makki, et al.
Clinical Therapeutics|October 28, 2015
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese SubjectsJiuhong Zha, Prajakta S Badri, Bifeng Ding, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2015
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-RitonavirPrajakta S Badri, Sandeep Dutta, Haoyu Wang, et al.
Antiviral Therapy|September 2, 2016
Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trialsAkshanth R Polepally, Prajakta S Badri, Apurvasena Parikh, et al.
Journal of Hepatology|February 4, 2015
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvirRajeev M Menon, Prajakta S Badri, Tianli Wang, et al.
Pageof 2